Literature DB >> 11097170

Prevalence, quality of life and psychosocial function in obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany.

H J Grabe1, C Meyer, U Hapke, H J Rumpf, H J Freyberger, H Dilling, U John.   

Abstract

BACKGROUND: Despite the worldwide relevance of obsessive-compulsive disorder (OCD) there are considerable differences in prevalence rates and gender ratios between the studies and a substantial lack of prevalence data on subclinical OCD. Moreover, data on quality of life and on psychosocial function of subjects with OCD and subclinical OCD in the general population are missing to date.
METHODS: German versions of the DSM-IV adapted Composite International Diagnostic Interview were administered to a representative sample of 4075 persons aged 18-64 years living in a northern German region. Specific DSM-IV based criteria for subclinical OCD were used.
RESULTS: The life-time prevalence rates for OCD and subclinical OCD were 0.5% and 2%, respectively. Twelve month prevalence rates were 0.39% and 1.6%, respectively. The gender female:male ratio was 5.7 in OCD and 1.2 in subclinical OCD. In various measures of psychosocial function and quality of life, OCD and subclinical OCD were significantly impaired. However, subclinical OCD subjects did not visit mental health professionals more often than controls.
CONCLUSION: Due to different epidemiological characteristics subclinical OCD might represent a syndrome distinct from OCD which is also associated with significant impairments in personal and interpersonal functions and in quality of life.

Entities:  

Mesh:

Year:  2000        PMID: 11097170     DOI: 10.1007/s004060070017

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  31 in total

1.  The prevalence and correlates of neurotic disorders among undergraduates at a mainland Chinese university.

Authors:  Changgui Kou; Xiangfei Meng; Bing Xie; Yanfen Chen; Qiong Yu; Jieping Shi; Yaqin Yu; Carl D'Arcy; Yueqin Huang
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-04-11       Impact factor: 4.328

2.  Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment.

Authors:  Yuki Adam; Gunther Meinlschmidt; Andrew T Gloster; Roselind Lieb
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-02       Impact factor: 4.328

3.  Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.

Authors:  Michael Rufer; Iver Hand; Heike Alsleben; Anne Braatz; Jürgen Ortmann; Birgit Katenkamp; Susanne Fricke; Helmut Peter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

4.  Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency.

Authors:  J L K Van Hove; J Steyaert; G Matthijs; E Legius; P Theys; R Wevers; A Romstad; L B Møller; K Hedrich; D Goriounov; N Blau; C Klein; P Casaer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 5.  The burden of mental disorders.

Authors:  William W Eaton; Silvia S Martins; Gerald Nestadt; O Joseph Bienvenu; Diana Clarke; Pierre Alexandre
Journal:  Epidemiol Rev       Date:  2008-09-19       Impact factor: 6.222

6.  Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls.

Authors:  Jonathan D Huppert; H Blair Simpson; Kore J Nissenson; Michael R Liebowitz; Edna B Foa
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 7.  [Obsessive-compulsive disorder: psychosocial consequences and quality of life: a review].

Authors:  M Hauschildt; S Moritz
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

Review 8.  [Epidemiology and health care situation of obsessive-compulsive disorders].

Authors:  U Voderholzer; S Schlegl; A K Külz
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

Review 9.  Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment.

Authors:  Mythily Subramaniam; Pauline Soh; Janhavi Ajit Vaingankar; Louisa Picco; Siow Ann Chong
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

10.  Brain activation during cognitive planning in twins discordant or concordant for obsessive-compulsive symptoms.

Authors:  Anouk den Braber; Dennis van 't Ent; Danielle C Cath; Judith Wagner; Dorret I Boomsma; Eco J C de Geus
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.